House appropriators are demanding that FDA dramatically revise its compounding policies, suggesting in report language that the agency overreached its statutory authority by penning a memorandum of understanding that covers dispensing, and that the agency went against Congressional intent by prohibiting office-use compounding.
No comments:
Post a Comment